CJC-1295 No DAC
$44.00 – $76.00Price range: $44.00 through $76.00
Shipping
Tested
Checkout
Third-Party Lab Results
Transparency is our priority. Download the full HPLC and Mass Spectrometry reports for the current batch #88291. Tested on Oct 24, 2023.
DOWNLOAD FULL REPORT (PDF)This blend combines two widely studied research peptides used in endocrine signaling models: CJC-1295 (No DAC), a growth hormone–releasing hormone (GHRH) analogue, and Ipamorelin, a growth hormone secretagogue receptor (GHSR) agonist often studied within ghrelin-pathway research. In controlled laboratory settings, the combination is used to explore multi-pathway growth hormone axis signaling, including how GHRH receptor stimulation and GHSR activation may interact within standardized assay systems. Supplied strictly for qualified laboratory and educational research use. Not for human or veterinary use.
CJC-1295 (No DAC) is typically used as a GHRH-pathway research tool to study pituitary signaling and GH release mechanisms, while ipamorelin is used to study GHSR-mediated signaling. Because these peptides act through distinct receptor systems, researchers may evaluate them together in comparative or combination designs to examine pathway crosstalk and combined signaling outputs.
Blend composition:
- CJC-1295 (No DAC): 5 mg
- Ipamorelin: 5 mg
- Total peptide content: 10 mg
Common research characteristics:
- Targets studied: GHRH receptor (CJC-1295 No DAC) + GHSR/ghrelin receptor (Ipamorelin)
- Research focus areas: GH-axis signaling, receptor pharmacology, endocrine feedback modeling, biomarker assays
- Format: Commonly supplied as a lyophilized blend for research handling and storage stability
All peptides are supplied as sterile, lyophilized powder and are stable when handled correctly.
- On arrival: Store vials in a cool, dry place away from heat and direct sunlight.
- Long-term (powder): For optimal longevity, keep lyophilized peptides refrigerated to help maintain integrity.
- After reconstitution: Use an appropriate research diluent (for example, BAC water). Store the reconstituted solution in the refrigerator and use within 20–30 days for best stability.
Note: Minimize exposure to moisture and repeated freeze–thaw cycles. Follow your institution's safety procedures when handling research materials.
Q1: What is included in the CJC-1295 (No DAC) + Ipamorelin blend?
A1: The blend contains CJC-1295 (No DAC) 5 mg and ipamorelin 5 mg, for a total of 10 mg of peptide content.
Q2: What does “No DAC” mean for CJC-1295?
A2: “No DAC” indicates the peptide is not conjugated to a drug affinity complex (DAC) modification. Researchers may select non-DAC versions when they want a shorter-acting GHRH-analog profile in certain assay designs.
Q3: What receptors are studied with this blend?
A3: CJC-1295 (No DAC) is studied for GHRH receptor signaling, while ipamorelin is studied for growth hormone secretagogue receptor (GHSR/ghrelin receptor) signaling.
Q4: Why do researchers study CJC-1295 with ipamorelin together?
A4: Because they act on different receptor pathways related to GH-axis regulation, researchers may evaluate them together to study combined signaling behavior and pathway interaction in controlled models.
Q5: How should this peptide blend be stored for lab use?
A5: Store sealed, dry, and protected from light according to your lab’s SOP. Many labs use cold storage for peptides and minimize moisture exposure and repeated temperature cycling.
Researcher Reviews
Frequently Bought Together
5-amino-1mq 5MG
ACE-031


Reviews
There are no reviews yet.